One embodiment of the present invention relates to a production method of a .sup.226Ra target, a production method of .sup.225Ac, or an electrodeposition solution for producing a .sup.226Ra target, and the production method of a .sup.226Ra target includes an electrodeposition step of electrodepositing a .sup.226Ra-containing substance on a substrate by using an electrodeposition solution that contains .sup.226Ra ions and a pH buffer.

Methods and systems are provided for continuous-flow production of radioisotopes with high specific activity. Radioisotopes with high specific activity produced according to the methods described are also provided. The methods can include causing a liquid capture matrix to contact a target containing a target nuclide; irradiating the target with radiation, ionizing radiation, particles, or a combination thereof to produce the radionuclides that are ejected from the target and into the capture matrix; and causing the liquid capture matrix containing the radionuclides to flow from the target to recover the capture matrix containing the radionuclides with high specific activity. The methods are suitable for the production of a variety of radionuclides. For example, in some aspects the target nuclide is .sup.237Np, and the radionuclide is .sup.238Np that decays to produce .sup.238Pu. In other aspects, the target nuclide is .sup.98Mo, and the radionuclide is .sup.99Mo that decays to produce .sup.99mTc.

An apparatus for producing .sup.99Mo from a plurality of .sup.100Mo targets through a photo-nuclear reaction on the .sup.100Mo targets. The apparatus comprises: (i) an electron linear accelerator component; (ii) a converter component capable of receiving the electron beam and producing therefrom a shower of bremsstrahlung photons; (iii) a target irradiation component for receiving the shower of bremsstrahlung photons for irradiation of a target holder mounted and positioned therein. The target holder houses a plurality of .sup.100Mo target discs. The apparatus additionally comprises (iv) a target holder transfer and recovery component for receiving, manipulating and conveying the target holder by remote control; (v) a first cooling system sealingly engaged with the converter component for circulation of a coolant fluid therethrough; and (vi) a second cooling system sealingly engaged with the target irradiation component for circulation of a coolant fluid therethrough.

An equatorial anthropic radiation source and a method of making an equatorial anthropic radiation source are described. The radiation source is useful in diagnostic imaging applications in healthcare or other industries (e.g. computerized three-dimensional segmental imaging; Crompton scattering imaging techniques; radiation detector check and calibration, in particular CdZnTe detectors commonly used in medical imaging).

A new column-based purification system and approach are described for rapid separation and purification of the alpha-emitting therapeutic radioisotope .sup.211At from dissolved cyclotron targets that provide highly reproducible product results with excellent .sup.211At species distributions and high antibody labeling yields compared with prior art manual extraction results of the prior art that can be expected to enable enhanced production of purified .sup.211At isotope products suitable for therapeutic medical applications such as treatment of cancer in human patients.

An irradiation target for the production of radioisotopes, comprising at least one plate defining a central opening and an elongated central member passing through the central opening of the at least one plate so that the at least one plate is retained thereon, wherein the at least one plate and the elongated central member are both formed of materials that produce molybdenum-99 (Mo-99) by way of neutron capture.

A method for producing lead-212 of very high radiological purity from an aqueous solution comprising thorium-228 and daughters thereof. Manufacture of radiopharmaceuticals based on lead-212, which are useful in nuclear medicine and, in particular, in targeted alpha radiation therapy for the treatment of cancers.

Apparatuses and methods for production of molybdenum targets, and the formed molybdenum targets, used to produce Tc-99m are described. The target includes a copper support plate having a front face and a back face. The copper support plate desirably has dimensions of thickness of about 2.8 mm, a length of about 65 mm and a width of about 30 mm; and the copper support plate desirably has either a circular or an elliptical cavity centrally formed therein by pressing molybdenum powder into the front face with a depth of about 200-400 microns. Also, the copper support plate includes cooling channels dispensed at the back face; wherein the copper support plate is water cooled by a flow of water during irradiation by a proton beam. Molybdenum powder is embedded and compressed onto the cavity of the copper support plate thereby creating a thin layer of molybdenum onto the copper support plate.

The present invention comprises a method for the generation of .sup.227Th of pharmaceutically tolerable purity comprising i) preparing a generator mixture comprising .sup.227Ac, .sup.227Th and .sup.223Ra; ii) loading said generator mixture onto a strong base anion exchange resin; iii) eluting a mixture of said .sup.223Ra and .sup.227Ac from said strong base anion exchange resin using a first mineral acid in an aqueous solution; iv) eluting .sup.227Th from said strong base anion exchange resin using a second mineral acid in an aqueous solution whereby to generate a first .sup.227Th solution containing contaminant .sup.223Ra and .sup.227Ac; v) loading the first .sup.227Th solution onto a strong acid cation exchange resin; vi) eluting at least a part of the contaminant .sup.223Ra and .sup.227Ac from said strong acid cation exchange resin using a third mineral acid in aqueous solution; and vii) eluting the .sup.227Th from said strong acid cation exchange resin using a first aqueous buffer solution to provide a second .sup.227Th solution. Purified thorium-227 of pharmaceutical purity and a pharmaceutical composition comprising the same are also provided.

A facility for producing radioisotopes. The facility includes at least one target holder. The target holder is configured to receive a target that includes a compound to be irradiated with an accelerated particle beam. The facility includes a cyclotron for producing the accelerated particle beam. The cyclotron includes at least one accelerating cavity within which the beam is subjected to a radiofrequency electric field in order to be accelerated and to a magnetic field enabling it to travel through the cavity several times, describing orbits about an axis of the cyclotron. The magnetic field is produced by at least one coil. The at least one target holder is inside the at least one coil as observed along the axis of the cyclotron. The at least one coil does not have symmetry of revolution about the axis.